Clinical Trials and Studies
Some clinical trials have suspended enrollment until further notice due to COVID-19 considerations.
Digestive Disorders
- Act Fast Study for Patients with Colorectal Cancer or Colorectal Lesion
- Chronotherapy in Ulcerative Colitis
- Colonoscopy Research Study
- Efavaleukin Alfa Treatment for People with Ulcerative Colitis
- FORTE Study for Colorectal Cancer Prevention
- Gastrojejunostomy in Gastric Outlet Obstruction
- Growth of Colon Tissue to Evaluate GI
- Inflammatory Bowel Disease (IBD) Registry
- New Treatment Development for People with Crohn's Disease
- Pancreatic Cancer Screening Study
- Paradoxical Diarrhea Treatment Study
- PATENT-E Study for Chronic Benign Stricture
- Study of Eating Patterns and Alcohol Consumption in Patients with Advanced Tubular Adenoma
- The COSMID Study for Patients with Diverticulitis
- The Impact of Sleep on Ulcerative Colitis
Gastrointestinal Cancers
- Act Fast Study for Patients with Colorectal Cancer or Colorectal Lesion
- Adenoma and Second Primary Prevention Trial
- Advanced G3 Non-Small Cell Gastroenteropancreatic Neuroendocrine Carcinomas Treatment Study
- Advanced/Metastatic Colorectal Cancer with HER-2 Amplification Treatment Study
- Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
- Colonoscopy Research Study
- Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study
- Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer
- EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients
- FORTE Study for Colorectal Cancer Prevention
- Growth of Colon Tissue to Evaluate GI
- High Risk Anal Cancer Treatment Study
- Initial Feasibility Study to Treat Pancreatic Cancer With a Planar LDR Source
- Pancreatic Cancer Screening Study
- Refractory Small Bowel Adenocarcinoma Treatment Study
- Retrospective Chart Review of Patients with Fibrolamellar Carcinoma
- Study for Patients with Hepatocellular Carcinoma (HCC)
- Study of Eating Patterns and Alcohol Consumption in Patients with Advanced Tubular Adenoma
- Testing Diet Intervention Versus Non-Diet Intervention for Management of Bowel Symptoms in Rectal Cancer Survivors
- The COMMIT Study: Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer
- The DECREASE Study: Treatment of Early-Stage Anal Cancer
- Treatment Study for Patients With Stage III Colon Cancer
- Veliparib, Pembrolizumab, and Combination Chemotherapy in Treating Patient With Locally Advanced Rectal Cancer